HOME >> BIOLOGY >> NEWS
Molecular rendezvous caught on camera

This release is also available in German.

The body is an almost perfect machine. For it to function properly, each individual component, that is each molecule, must reliably fulfill its specific function. Each molecule must thus "recognize" other molecules and work with them. A team of researchers from the Max Planck Institute for Solid State Research in Stuttgart, the Fraunhofer Institute in Freiburg, and King's College in London, has now successfully filmed pairs of molecules during the recognition process. As reported to the journal Angewandte Chemie, the shapes of the molecules change to accommodate each other.

Like humans, molecules also "greet" each other with a kind of "handshake". Anyone who has tried to shake someone's right hand with his or her own left will have had a little trouble: the right and left hands do not fit together. In the same way, some molecules that exist in both a right-handed (D) and left-handed (L) configuration can tell if others they encounter are the D or L form.

Magali Lingenfelder and colleagues at the Max Planck Institute for Solid State Research have now been able to use scanning tunneling microscopy to take a series of pictures that follow in detail the "encounters" of diphenylalanine molecules adsorbed onto a substrate. (Diphenylalanine is the central structural unit within polypeptide fibers found in the brains of Alzheimer's patients.) The "film sequences" reveal that only molecules with the same chirality (handedness) readily aggregate into pairs and chains.

Just as in a handshake, it is not enough that the right hands hold each other. To grip each other firmly, the two hands must adapt to fit their shapes together. Molecules do the same: close examination of the "film", in conjunction with theoretical calculations by researchers from King's College, prove that this type of dynamic accommodation of shape also o
'"/>

Contact: Magal Lingenfelder
m.lingenfelder@fkf.mpg.de
49-711-689-1620
John Wiley & Sons, Inc.
2-May-2007


Page: 1 2

Related biology news :

1. Molecular detectors may refine cancer treatment
2. Story ideas from Molecular & Cellular Proteomics
3. 2007 Image of the Year: Molecular imaging relates human brain chemistry to aggressive behavior
4. Molecular motors may speed nutrient processing
5. Molecular tools make the cut
6. Genomatix and Molecular Connections form strategic partnership
7. Molecular motors and brakes work together in cells
8. Molecular link between inflammation and cancer discovered
9. Molecular on/off switch controls immune defenses against viruses
10. Molecular marker on stem cells aids research, perhaps therapies
11. Molecular mechanism provides intra-cellular traffic signal

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Molecular rendezvous caught camera

(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
(Date:7/30/2015)... (PRWEB) , ... July 31, 2015 , ... Ralco is ... Center at the Lyon County Fair to be held August 5-9 in Marshall. The ... where their meals come from and how agriculture impacts their daily lives. This unique ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: